S298: CS585 IS A FIRST-IN-CLASS COMPOUND TARGETING THE IP RECEPTOR FOR PREVENTION OF THROMBOSIS WITHOUT INCREASED RISK OF BLEEDING

• S. Lambert,
• R. Adili,
• P. Yalavarthi,
• N. Rhoads,
• B. Dahlof,
• A. White,
• N. Bergh,
• M. Holinstat

Affiliations

S. Lambert

1 Pharmacology, University of Michigan Medical School, Ann Arbor, United States of America

R. Adili

1 Pharmacology, University of Michigan Medical School, Ann Arbor, United States of America

P. Yalavarthi

1 Pharmacology, University of Michigan Medical School, Ann Arbor, United States of America

N. Rhoads

1 Pharmacology, University of Michigan Medical School, Ann Arbor, United States of America

B. Dahlof

2 Cereno Scientific

A. White

4 Medicinal Chemistry

N. Bergh

2 Cereno Scientific

M. Holinstat

1 Pharmacology, University of Michigan Medical School, Ann Arbor, United States of America